RxDoctor Payments Data

Rimsky Denis, MD

Interventional Cardiology · Miami, FLNPI 1710399613

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $14,812 of the $24,007 with a category attached, or 61.7%. 20 manufacturers reported payments, led by Biotronik Inc. at 49.5% of the total. Reporting peaked in 2023 at $6,026 and has fallen 90.5% since, to $574 in 2025.

$24,007in general payments, 2019–2025

Across 160 payments — averaging $150.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik Inc.$12K
  • Medtronic$3K
  • Abbott$3K
  • Philips North America LLC$2K
  • Edwards Lifesciences$2K
  • Boston Scientific$1K
  • plus $2K from 14 others
$1,221,960in research payments, 2019–2025

Across 93 payments — averaging $13,139 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$550K
  • Amgen$369K
  • Novartis$103K
  • Genentech, Inc.$85K
  • Boehringer Ingelheim International GmbH$74K
  • Pfizer$28K
  • plus $13K from 1 others

What the payments were for

  • Speaking & faculty fees$1561%
  • Grants$2,2509%
  • Travel & lodging$14,81262%
  • Food & beverage$6,78828%
  • Education$10%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,007 in reported general payments places this provider in the 75th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$64,507
Medicare patients
104
Services billed
432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →